Literature DB >> 1438302

A conserved double-stranded RNA-binding domain.

D St Johnston1, N H Brown, J G Gall, M Jantsch.   

Abstract

We have identified a double-stranded (ds)RNA-binding domain in each of two proteins: the product of the Drosophila gene staufen, which is required for the localization of maternal mRNAs, and a protein of unknown function, Xlrbpa, from Xenopus. The amino acid sequences of the binding domains are similar to each other and to additional domains in each protein. Database searches identified similar domains in several other proteins known or thought to bind dsRNA, including human dsRNA-activated inhibitor (DAI), human trans-activating region (TAR)-binding protein, and Escherichia coli RNase III. By analyzing in detail one domain in staufen and one in Xlrbpa, we delimited the minimal region that binds dsRNA. On the basis of the binding studies and computer analysis, we have derived a consensus sequence that defines a 65- to 68-amino acid dsRNA-binding domain.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1438302      PMCID: PMC50466          DOI: 10.1073/pnas.89.22.10979

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon.

Authors:  E Meurs; K Chong; J Galabru; N S Thomas; I M Kerr; B R Williams; A G Hovanessian
Journal:  Cell       Date:  1990-07-27       Impact factor: 41.582

2.  RNA recognition: towards identifying determinants of specificity.

Authors:  D J Kenan; C C Query; J D Keene
Journal:  Trends Biochem Sci       Date:  1991-06       Impact factor: 13.807

3.  oskar mRNA is localized to the posterior pole of the Drosophila oocyte.

Authors:  J Kim-Ha; J L Smith; P M Macdonald
Journal:  Cell       Date:  1991-07-12       Impact factor: 41.582

4.  Profile analysis: detection of distantly related proteins.

Authors:  M Gribskov; A D McLachlan; D Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

5.  The DNA sequence of the gene (rnc) encoding ribonuclease III of Escherichia coli.

Authors:  P E March; J Ahnn; M Inouye
Journal:  Nucleic Acids Res       Date:  1985-07-11       Impact factor: 16.971

6.  Characterization of a vaccinia virus-encoded double-stranded RNA-binding protein that may be involved in inhibition of the double-stranded RNA-dependent protein kinase.

Authors:  J C Watson; H W Chang; B L Jacobs
Journal:  Virology       Date:  1991-11       Impact factor: 3.616

7.  Structure of genes for virus-associated RNAI and RNAII of adenovirus type 2.

Authors:  G Akusjärvi; M B Mathews; P Andersson; B Vennström; U Pettersson
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

8.  The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase.

Authors:  H W Chang; J C Watson; B L Jacobs
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

9.  Mechanism of interferon action: cDNA structure, expression, and regulation of the interferon-induced, RNA-dependent P1/eIF-2 alpha protein kinase from human cells.

Authors:  D C Thomis; J P Doohan; C E Samuel
Journal:  Virology       Date:  1992-05       Impact factor: 3.616

10.  Characterization of double-stranded-RNA-activated kinase that phosphorylates alpha subunit of eukaryotic initiation factor 2 (eIF-2 alpha) in reticulocyte lysates.

Authors:  D H Levin; R Petryshyn; I M London
Journal:  Proc Natl Acad Sci U S A       Date:  1980-02       Impact factor: 11.205

View more
  197 in total

1.  Distinct roles of two conserved Staufen domains in oskar mRNA localization and translation.

Authors:  D R Micklem; J Adams; S Grünert; D St Johnston
Journal:  EMBO J       Date:  2000-03-15       Impact factor: 11.598

2.  Determination of preferential binding sites for anti-dsRNA antibodies on double-stranded RNA by scanning force microscopy.

Authors:  M Bonin; J Oberstrass; N Lukacs; K Ewert; E Oesterschulze; R Kassing; W Nellen
Journal:  RNA       Date:  2000-04       Impact factor: 4.942

3.  A cis-acting element in the 3'-untranslated region of human TNF-alpha mRNA renders splicing dependent on the activation of protein kinase PKR.

Authors:  F Osman; N Jarrous; Y Ben-Asouli; R Kaempfer
Journal:  Genes Dev       Date:  1999-12-15       Impact factor: 11.361

4.  Modular structure of PACT: distinct domains for binding and activating PKR.

Authors:  G A Peters; R Hartmann; J Qin; G C Sen
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

5.  Straightening of bulged RNA by the double-stranded RNA-binding domain from the protein kinase PKR.

Authors:  X Zheng; P C Bevilacqua
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

6.  A human sequence homologue of Staufen is an RNA-binding protein that is associated with polysomes and localizes to the rough endoplasmic reticulum.

Authors:  R M Marión; P Fortes; A Beloso; C Dotti; J Ortín
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

7.  Substrate recognition by a eukaryotic RNase III: the double-stranded RNA-binding domain of Rnt1p selectively binds RNA containing a 5'-AGNN-3' tetraloop.

Authors:  R Nagel; M Ares
Journal:  RNA       Date:  2000-08       Impact factor: 4.942

Review 8.  The beginning of the end.

Authors:  D St Johnston
Journal:  EMBO J       Date:  2001-11-15       Impact factor: 11.598

9.  A novel family of RNA tetraloop structure forms the recognition site for Saccharomyces cerevisiae RNase III.

Authors:  H Wu; P K Yang; S E Butcher; S Kang; G Chanfreau; J Feigon
Journal:  EMBO J       Date:  2001-12-17       Impact factor: 11.598

10.  The C-terminal, third conserved motif of the protein activator PACT plays an essential role in the activation of double-stranded-RNA-dependent protein kinase (PKR).

Authors:  Xu Huang; Brian Hutchins; Rekha C Patel
Journal:  Biochem J       Date:  2002-08-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.